Phesgo® Subcutaneous Injection for HER2+ Breast Cancer Treatment | No Style Like
Price range: EGP78000 through EGP140000
What is Phesgo®?
Phesgo® is an innovative fixed-dose combination of pertuzumab and trastuzumab, administered under the skin rather than intravenously. It is designed to treat HER2-positive breast cancer, both in early and advanced stages. By delivering two powerful targeted therapies together, Phesgo® provides a more convenient and faster alternative to traditional intravenous infusion.
Uses of Phesgo®
Treatment of early-stage HER2-positive breast cancer.
Treatment of metastatic or locally advanced HER2-positive breast cancer.
Reduces the risk of cancer recurrence after surgery.
Enhances treatment outcomes when combined with chemotherapy or hormonal therapy.
Benefits of Phesgo®
Combines two proven targeted therapies in one injection.
Faster administration: given in just 5–8 minutes compared to hours with IV infusions.
Convenient for patients, minimizing time in clinics or hospitals.
Clinically proven efficacy in controlling HER2-positive breast cancer.
Improved patient quality of life due to reduced treatment burden.
Dosage & Administration
Initial dose: 1200mg pertuzumab / 600mg trastuzumab (administered in ~8 minutes).
Maintenance dose: 600mg/600mg (administered in ~5 minutes).
Dosing schedule: every 3 weeks.
Treatment duration: varies based on clinical protocol and patient’s condition.
Side Effects of Phesgo®
Like all cancer treatments, Phesgo® can cause side effects. The most common include:
Fatigue and loss of appetite.
Nausea, vomiting, or diarrhea.
Hair loss (often due to accompanying chemotherapy).
Injection site reactions (redness, swelling, or pain).
Decreased heart function (patients must undergo regular cardiac monitoring).
Warnings & Precautions
Contraindicated in patients allergic to pertuzumab or trastuzumab.
Cardiac function must be checked before and during treatment.
Not recommended during pregnancy or breastfeeding.
Should only be administered under the supervision of a healthcare professional.
Drug Interactions
Possible interaction with anthracyclines (e.g., doxorubicin), increasing cardiotoxicity risk.
Caution when combined with other chemotherapy agents (e.g., docetaxel, paclitaxel).
Always inform your doctor about all medications and supplements being taken.
Why Buy Phesgo® from No Style Like?
100% genuine products directly from trusted suppliers.
Safe storage and cold-chain delivery.
Fast nationwide shipping.
24/7 medical consultation support.
Competitive prices and exclusive patient discounts.
Customer Reviews
⭐⭐⭐⭐⭐ “Phesgo® made my treatment sessions so much easier and faster.”
⭐⭐⭐⭐⭐ “I felt more comfortable compared to long IV infusions.”
⭐⭐⭐⭐ “Some side effects appeared, but overall I managed well.”
Frequently Asked Questions (FAQs)
1. What is Phesgo® used for?
Phesgo® treats HER2-positive breast cancer by combining two targeted therapies in a single injection.
2. How long does Phesgo® injection take?
The initial dose takes about 8 minutes, while maintenance doses take about 5 minutes.
3. Can men use Phesgo®?
Yes, in rare cases of HER2-positive breast cancer in men.
4. Does Phesgo® cause hair loss?
Phesgo® itself does not, but chemotherapy given with it may cause hair loss.
5. Is Phesgo® safe during pregnancy?
No, it must not be used during pregnancy, and women should avoid conceiving for 7 months after the last dose.
6. How should Phesgo® be stored?
In the refrigerator at 2–8°C. Do not freeze.
7. How many doses are needed?
The number of doses depends on the treatment plan, typically between 6 and 18.
8. Does insurance cover Phesgo®?
Coverage depends on the country and insurance policy.
9. Is Phesgo® a replacement for chemotherapy?
No, it is usually given alongside chemotherapy for maximum effectiveness.
10. Where can I buy original Phesgo®?
From licensed pharmacies or trusted online stores like No Style Like.
| التركيز |
|---|
